Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling ...
The Pharma Letter

Verrica announces launch of Ycanth in Japan by Torii

US dermatologics specialist Verrica Pharmaceuticals) today announced the launch of Ycanth in Japan by its partner, Torii Pharmaceutical, a wholly-owned subsidiary of Japan’s Shionogi, for the ...
Portland Press Herald

Bath honors ties to Japanese city with torii gate, memorial garden

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...
Japan Today

JT, Torii conclude agreement to market novel anti-HIV single-tablet regimen in Japan

Japan Tobacco Inc and Torii Pharmaceutical Co Ltd, JT’s pharmaceutical subsidiary, have announced the conclusion of an agreement to market an anti-HIV single-tablet regimen containing JT’s original ...

Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Announces Launch of YCANTH for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

Verrica Pharmaceuticals Inc. ("Verrica") (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring ...